Antiparkinsonian trophic action of glial cell line-derived neurotrophic factor and transforming growth factor β1 is enhanced after co-infusion in rats

Exp Neurol. 2010 Nov;226(1):136-47. doi: 10.1016/j.expneurol.2010.08.016. Epub 2010 Aug 14.

Abstract

The objective was to analyze functional effects of the combination of GDNF and TGF-β1 in the retrograde model of Parkinsonism in rats, based on the intrastriatal infusion of 6-hydroxydopamine, which leads to protracted and progressive cell death in the substantia nigra. Hemiparkinsonian rats were implanted with osmotic minipumps 2 months after striatal lesion, pumps delivering GDNF alone (10 ng/day), TGF-β1 alone (2 ng/day), or a GDNF and TGF-β1 combination. The findings confirmed that GDNF alone has potent dopaminotrophic effects but they also revealed, for the first time, that GDNF and TGF-β1 co-infusion led to stronger trophic effects relative to the infusion of GDNF alone. TGF-β1 allowed further reducing dopamine receptor hypersensitivity, and potentiated GDNF-mediated effects. This cooperation could be accounted for by the recruitment of GFRα1 on striatal membranes, and by enhanced expression and activation of TH through augmented pSer31TH and pSer40TH. Co-infusion induced striatal sprouting, as revealed by augmentation of p21-Arc, stathmin, and synaptophysin, and led to a reliable recovery of phenotypic expression of TH in surviving nigral neurons. Functional recovery and improvement of TH signal in the nigrostriatal system were long-lasting and sustained, remaining after cessation of trophic infusion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Amphetamine
  • Animals
  • Antiparkinson Agents*
  • Apomorphine / pharmacology
  • Behavior, Animal / drug effects
  • Blotting, Western
  • Central Nervous System Stimulants
  • Dopamine Agonists / pharmacology
  • Glial Cell Line-Derived Neurotrophic Factor / administration & dosage
  • Glial Cell Line-Derived Neurotrophic Factor / pharmacology*
  • Glial Cell Line-Derived Neurotrophic Factor Receptors / biosynthesis
  • Immunohistochemistry
  • Infusion Pumps, Implantable
  • Male
  • Microinjections
  • Neostriatum
  • Oxidopamine
  • Parkinson Disease, Secondary / chemically induced
  • Parkinson Disease, Secondary / drug therapy*
  • Parkinson Disease, Secondary / pathology
  • Rats
  • Rats, Wistar
  • Stereotyped Behavior
  • Sympatholytics
  • Transforming Growth Factor beta1 / administration & dosage
  • Transforming Growth Factor beta1 / pharmacology*

Substances

  • Antiparkinson Agents
  • Central Nervous System Stimulants
  • Dopamine Agonists
  • Glial Cell Line-Derived Neurotrophic Factor
  • Glial Cell Line-Derived Neurotrophic Factor Receptors
  • Sympatholytics
  • Transforming Growth Factor beta1
  • Oxidopamine
  • Amphetamine
  • Apomorphine